Why are syphilis cases rising — and how serious is the current situation in Europe?

Syphilis is a sexually transmitted infection (STI) caused by Treponema pallidum. Recent public health data show increasing case numbers across parts of Europe. In this episode, we explain what this rise means, how syphilis progresses, and when testing is essential.

You’ll learn:

• Why syphilis rates have increased, including changes in testing, reporting, and sexual health behaviours

• The stages of syphilis: primary (painless ulcer), secondary (rash, systemic symptoms), latent, and tertiary disease

• How untreated infection can affect the nervous system, heart, and other organs

• The importance of early diagnosis to prevent long-term complications

• How syphilis is diagnosed through blood testing and clinical assessment

• Why prompt antibiotic treatment is effective when infection is confirmed

• When testing is recommended after unprotected sex or new sexual partners

• Situations where antibiotic requests may be declined without appropriate testing

We also discuss partner notification and prevention strategies.

This episode complements our full clinical guide:

SCARY NEWS ABOUT SYPHILIS

https://www.mobidoctor.eu/blog/scary-news-about-syphilis

Mobi Doctor provides online medical consultations across Europe. Testing and treatment decisions are based on individual risk assessment and established clinical guidelines.

Does birth control affect libido? Hormonal contraception and sex drive explained for women in Europe.

In this episode, we examine how hormonal birth control may influence libido, sexual desire, and arousal, and how online medical assessment works across the EU.

You’ll learn:

• How combined pills, mini pills, patches, and vaginal rings affect hormones

• The role of oestrogen, progesterone, and testosterone in sexual desire

• Why some women report lower libido — and why others do not

• Psychological, relationship, and health factors that also influence sex drive

• How doctors assess side effects during an online contraceptive review

• When a contraceptive change may be considered

• Situations where a prescription request may be declined for safety reasons

We clarify what current medical evidence says, what remains individual, and how side effects are evaluated before prescribing.

This episode reflects the clinical approach used by Mobi Doctor, where contraception requests are reviewed by a registered physician based on medical history, risk factors, and EU prescribing guidelines.

Read the full medical guide and transcript here:

https://www.mobidoctor.eu/blog/does-birth-control-affect-libido

How do you differentiate migraines from other headaches? Key symptoms, diagnostic criteria, and red flags explained.

In this episode, we clarify how migraines differ from tension headaches, cluster headaches, and secondary headaches, and how symptoms are medically assessed in Europe.

You’ll learn:

• The defining features of migraine (throbbing pain, nausea, light sensitivity, aura)

• How tension headaches typically present

• What makes cluster headaches distinct

• Red flag symptoms that require urgent in-person evaluation

• How doctors assess headache patterns during an online consultation

• When migraine treatment may be appropriate

• Situations where a prescription request may be declined for safety reasons

We explain the International Classification of Headache Disorders (ICHD-3) criteria in simple terms and outline when imaging or neurological referral may be necessary.

This episode reflects the clinical framework used by Mobi Doctor, where headache consultations are reviewed by a registered physician based on symptom history, frequency, risk factors, and EU prescribing standards.

Read the full medical guide and transcript here:

https://www.mobidoctor.eu/blog/how-to-differentiate-migrains-from-other-headaches

What are the essential facts about the birth control ring? Safety, effectiveness, and medical eligibility explained for women in Europe.

In this episode, we outline six clinically important facts about the vaginal birth control ring and how it is assessed during an online consultation in the EU.

You’ll learn:

• How the contraceptive ring works (combined oestrogen and progestogen release)

• Typical use effectiveness and correct insertion schedule (3 weeks in, 1 week out)

• Who may be medically eligible based on age, BMI, smoking status, and history

• Common side effects and when to seek medical advice

• Contraindications, including migraine with aura, clot risk, and certain conditions

• How online contraceptive reviews are conducted and documented

We explain how doctors assess cardiovascular risk factors, medication interactions, and safety criteria before prescribing. Not all requests are approved; prescriptions may be declined if clinical guidelines indicate increased risk or if further in-person evaluation is required.

This episode reflects the prescribing standards used by Mobi Doctor, where each contraception request is reviewed by a registered physician according to EU medical guidance.

Read the full guide and transcript here:

https://www.mobidoctor.eu/blog/6-essential-facts-about-the-birth-control-ring

What is scalp care and how do you manage common scalp conditions safely in Europe?

Scalp care explained: dandruff, seborrhoeic dermatitis, psoriasis, hair thinning, and when to seek medical advice.

In this episode, we outline the fundamentals of scalp health and how common scalp concerns are assessed during an online medical consultation in the EU.

You’ll learn:

• The difference between dandruff and seborrhoeic dermatitis

• How psoriasis affects the scalp and how it is identified

• Causes of itching, flaking, redness, and irritation

• How stress, hormones, and skin conditions influence scalp health

• When antifungal or medicated treatments may be considered

• Red flag symptoms that require in-person evaluation

• Situations where a treatment request may be declined for safety reasons

We explain how doctors assess symptom duration, severity, previous treatments, and medical history before recommending prescription options. Not all scalp conditions are suitable for remote management, particularly if infection, scarring hair loss, or systemic illness is suspected.

This episode reflects the clinical approach used by Mobi Doctor, where every consultation is reviewed by a registered physician according to EU medical standards.

Read the full guide and transcript here:

https://www.mobidoctor.eu/blog/scalp-care-101

How should scalp care be managed, and when do dandruff, seborrhoeic dermatitis, or psoriasis require medical assessment in Europe?

Scalp care explained: itching, flaking, hair thinning, inflammatory scalp conditions, and clinical red flags.

In this episode, we define scalp care in medical terms and explain how common scalp disorders are evaluated during an online consultation in the EU.

You’ll learn:

• The clinical difference between dandruff and seborrhoeic dermatitis

• How scalp psoriasis presents and how it is distinguished from other causes

• Common triggers of itching, redness, scaling, and irritation

• Causes of hair thinning, including inflammatory and hormonal factors

• When antifungal shampoos or prescription treatments may be appropriate

• Red flag symptoms such as infection, patchy hair loss, or severe inflammation

• Situations where a prescription request may be declined pending in-person review

We explain how doctors assess symptom pattern, duration, previous treatments, medical history, and photographs when appropriate. Some scalp conditions require physical examination, laboratory testing, or dermatology referral before treatment can be considered.

This episode reflects the clinical standards used by Mobi Doctor, where each consultation is reviewed by a registered physician in line with EU medical guidance.

Read the full guide and transcript here:

https://www.mobidoctor.eu/blog/scalp-care-101

How can you spot STIs and STDs early, and when should you get tested in Europe?

Spotting STIs explained: symptoms, asymptomatic infections, testing options, and when medical assessment is required.

In this episode, we clarify the difference between sexually transmitted infections (STIs) and sexually transmitted diseases (STDs), and how common infections are identified during clinical evaluation in the EU.

You’ll learn:

• Early symptoms of chlamydia, gonorrhoea, genital herpes, HPV, and syphilis

• Why many STIs are asymptomatic and require screening

• Typical signs such as unusual discharge, pain during urination, sores, rashes, or pelvic pain

• When urgent in-person assessment is necessary

• How online consultations assess sexual history and risk factors

• When laboratory testing is required before treatment can be considered

• Situations where a prescription request may be declined for safety reasons

We explain how doctors evaluate symptom timing, exposure risk, previous infections, and test results before recommending treatment. Empirical treatment is not always appropriate without confirmed diagnosis.

This episode reflects the clinical standards used by Mobi Doctor, where STI-related consultations are reviewed by a registered physician in accordance with EU medical guidelines.

Read the full guide and transcript here:

https://www.mobidoctor.eu/blog/spotting-stis-and-stds

What is the difference between Ozempic and Victoza for type 2 diabetes and weight management in Europe?

Ozempic vs Victoza explained: semaglutide vs liraglutide, dosing, effectiveness, side effects, and prescribing criteria.

In this episode, we compare two GLP-1 receptor agonists — Ozempic (semaglutide) and Victoza (liraglutide) — and clarify how they are medically assessed during an online consultation in the EU.

You’ll learn:

• How GLP-1 receptor agonists work to regulate blood glucose and appetite

• Key differences in dosing (weekly vs daily injection)

• Approved indications for type 2 diabetes and weight-related treatment

• Common side effects, including nausea and gastrointestinal symptoms

• Cardiovascular considerations and risk assessment

• Who may meet prescribing criteria based on BMI, HbA1c, and medical history

• Situations where a prescription request may be declined or require specialist input

We explain how doctors review blood test results, current medications, contraindications (such as certain endocrine conditions), and overall metabolic risk before treatment can be considered. Not all patients are suitable for GLP-1 therapy, and ongoing monitoring is essential.

This episode reflects the clinical standards used by Mobi Doctor, where each request is reviewed by a registered physician according to EU prescribing guidelines.

Read the full guide and transcript here:

https://www.mobidoctor.eu/blog/ozempic-vs-victoza

How do you tell the difference between scalp psoriasis and dandruff?

Scalp psoriasis vs dandruff explained: symptoms, scaling patterns, itching, inflammation, and treatment considerations in Europe.

In this episode, we clarify how these two common scalp conditions differ clinically and how they are assessed during an online medical consultation in the EU.

You’ll learn:

• How dandruff (mild seborrhoeic dermatitis) typically presents

• The defining features of scalp psoriasis, including thick plaques and silvery scale

• Differences in redness, inflammation, and spread beyond the hairline

• Common triggers and risk factors for each condition

• When antifungal shampoos may be appropriate

• When prescription treatments such as topical corticosteroids may be considered

• Red flag signs that require in-person dermatology evaluation

• Situations where a treatment request may be declined for safety reasons

We explain how doctors assess symptom duration, severity, previous response to treatment, and associated skin or joint symptoms before recommending therapy. Some cases require physical examination to confirm diagnosis.

This episode reflects the clinical standards used by Mobi Doctor, where each consultation is reviewed by a registered physician according to EU medical guidelines.

Read the full guide and transcript here:

https://www.mobidoctor.eu/blog/scalp-psoriasis-vs-dandruff

What is the difference between overweight and obese, and how is it medically defined in Europe?

Overweight vs obese explained: BMI thresholds, waist circumference, metabolic risk, and clinical assessment criteria.

In this episode, we clarify how overweight and obesity are defined using Body Mass Index (BMI) and why classification matters for long-term health risk in adults across the EU.

You’ll learn:

• The medical definition of overweight (BMI 25–29.9) and obesity (BMI ≥30)

• Obesity classes (Class I, II, III) and associated health risks

• Why waist circumference and body fat distribution are clinically relevant

• Links between excess weight and type 2 diabetes, hypertension, and cardiovascular disease

• When laboratory testing may be recommended

• How weight-related consultations are assessed online

• Situations where medication requests may be declined pending further evaluation

We explain how doctors assess BMI, comorbidities, medication history, and lifestyle factors before considering medical treatment options. Not all individuals with elevated BMI require medication, and some cases require in-person examination or specialist referral.

This episode reflects the clinical standards used by Mobi Doctor, where consultations are reviewed by a registered physician in line with EU medical guidance.

Read the full guide and transcript here:

https://www.mobidoctor.eu/blog/overweight-vs-obese